Progyny, Inc.
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.29B | $1.17B | $1.09B | $786.9M | $500.6M | $344.9M | $229.7M | $105.4M |
| Cost of Revenue | $984.2M | $913.9M | $849.8M | $619.6M | $388.5M | $274.8M | $184.2M | $86.0M |
| Gross Profit | $304.5M | $253.4M | $238.8M | $167.3M | $112.1M | $70.1M | $45.5M | $19.4M |
| Gross Margin | 23.6% | 21.7% | 21.9% | 21.3% | 22.4% | 20.3% | 19.8% | 18.4% |
| Operating Expenses | ||||||||
| Research & Development | $9.5M | — | — | — | — | — | — | — |
| SG&A Expense | $147.1M | $122.0M | $117.1M | $98.3M | $59.6M | $46.7M | $23.9M | $15.6M |
| Operating Income | $85.3M | $67.5M | $62.2M | $23.3M | $32.3M | $8.3M | $9.7M | $-3.5M |
| Operating Margin | 6.6% | 5.8% | 5.7% | 3.0% | 6.5% | 2.4% | 4.2% | -3.3% |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | $95.4M | $83.2M | $70.7M | $24.4M | $32.4M | $8.7M | $-8.6M | $-6.9M |
| Income Tax Expense | $36.9M | $28.9M | $8.7M | $-5.9M | $-33.3M | $-37.8M | $12.0K | $-1.8M |
| Net Income | $58.5M | $54.3M | $62.0M | $30.4M | $65.8M | $46.5M | $-8.6M | $661.0K |
| Net Margin | 4.5% | 4.7% | 5.7% | 3.9% | 13.1% | 13.5% | -3.7% | 0.6% |
| EPS (Basic) | $0.68 | $0.59 | $0.65 | $0.33 | $0.74 | $0.54 | $-0.08 | $0.00 |
| EPS (Diluted) | $0.65 | $0.57 | $0.62 | $0.30 | $0.66 | $0.47 | $-0.08 | $0.00 |
| Shares Outstanding (Basic) | 85.7M | 91.5M | 95.0M | 92.2M | 89.1M | 85.7M | 103.7M | 110.8M |
| Shares Outstanding (Diluted) | 89.9M | 95.4M | 100.7M | 100.0M | 100.4M | 99.1M | 103.7M | 110.8M |
| Dividends Per Share | — | — | — | — | — | — | — | — |